Navigation Links
Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009
Date:9/15/2009

HONG KONG, Sept. 15 /PRNewswire/ -- Data from multiple clinical trials of the world's first pro-healing stent, OrbusNeich's Genous Bio-engineered R stent, and preclinical data from Combo Bio-engineered Sirolimus Eluting Stent will be presented next week at the Transcatheter Cardiovascular Therapeutics symposium, TCT 2009, in San Francisco.

Robbert de Winter, M.D., Ph.D., of the Academic Medical Center in Amsterdam will provide the final 12-month outcomes from e-HEALING, a monitored, multi-center, worldwide (outside the United States) prospective registry with 5,000 enrolled patients. The oral presentation will take place at 1:16 p.m. PDT on Sept. 22 in room 104 at the Moscone Center.

In addition, de Winter and his colleagues will present a poster titled "Patients with diabetes mellitus in the worldwide e-HEALING registry have a low target lesion revascularization rate at 12-month follow-up." The poster can be reviewed from 8 a.m. PDT - 10 p.m. PDT on Sept. 22 in Hall D.

An additional poster titled "Routine use of an EPC-capturing stent in patients undergoing primary PCI for ST-segment elevation myocardial infarction: A prospective registry in all comers," will be presented by Jan-Henk Dambrink, M.D., Ph.D., of the Isala klieniken, Zwolle, Netherlands, and can be reviewed from 8 a.m. PDT - 10 p.m. PDT on Sept. 22 in Hall D.

Juan F Granada, M.D., medical director of the Skirball Center for Cardiovascular Research and assistant professor at Columbia University, New York, will present preclinical data of OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent, which is designed to combine the pro-healing technology used in OrbusNeich's Genous Bio-engineered R stent for rapid endothelial coverage and improved functionality with abluminal sirolimus sustained drug elution for the control of neointimal proliferation. The oral presentation titled "The OrbusNeich EPC-Co
'/>"/>

SOURCE OrbusNeich
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial
2. Calixa Therapeutics to Make Multiple Presentations on CXA-101 and CXA-101/tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis
4. Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
5. Clay Walkers Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research
6. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
7. Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
8. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
9. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
10. Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
11. New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , September 2, 2014 ... Genetics has become the first European company to obtain ... Generation Sequencing (NGS) bioinformatic pipeline for routine genetic testing. ... in raising the standards of routine genetic testing ... Data Driven Medicine platform to a wider market. ...
(Date:9/2/2014)... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... announced that the Company,s management will participate in the following ... Healthcare Conference, to be held at the Grand Hyatt New ... Stanley Asia Pacific Healthcare Day, to be held at the ... Healthcare & Technology Conference, to be held at the Wynn ...
(Date:9/2/2014)... , Sept. 2, 2014 Legal-Bay LLC, ... increase in capital and cash advance funding for ... System,s da Vinci Robot. With over 400k surgeries ... focuses on providing lawsuit cash advances for victims ... damage, lacerations to internal organs, burns to blood ...
Breaking Medicine Technology:Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2Sinovac to Participate in Upcoming Investor Conferences 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 3
... 7, 2011 Reportlinker.com announces that a new ... The 2011 Top Ten ... http://www.reportlinker.com/p0368704/The-2011-Top-Ten-World,s-Leading-Pharmaceutical-Companies.html A thought-provoking report ... major competitors in the worldwide pharmaceutical market. The ...
... 7, 2011 Reportlinker.com announces that a ... its catalogue: Aesthetic Devices ... be Driven by Improving Treatment Outcomes and ... http://www.reportlinker.com/p0409144/Aesthetic-Devices-Market-to-2017---Future-Growth-to-be-Driven-by-Improving-Treatment-Outcomes-and-Increase-in-Consumer-Confidence.html Aesthetic ...
Cached Medicine Technology:Reportlinker Adds The 2011 Top Ten World's Leading Pharmaceutical Companies 2Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence 2Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Lseat.com is one ... covers . All its products are user-friendly items; no professional ... original seat covers; they can slip right over the cars’ ... Now, the company’s website is filled with various kinds of ... its new designs of Jeep leather seat covers . ...
(Date:9/2/2014)... MA (PRWEB) September 02, 2014 A ... for everyone. But sometimes the onset of irritability, sadness, ... condition, reports the September 2014 Harvard Health Letter. ... response to everyday stresses. If they occur for long ... it's an indication to seek help," says Dr. Nancy ...
(Date:9/2/2014)... September 02, 2014 Researchers in New Delhi, ... developed mesothelioma after being exposed to asbestos-contaminated work clothes for ... the details of the report in a new article. ... the ESI Model Hospital say their patient was diagnosed ... Further investigation found that she had come in contact with ...
(Date:9/2/2014)... 2014 Eric Jimenez and Leah Ashley ... a revolutionary makeup application device. Designed to improve and ... in the palm of women’s hands to help them ... Color Me’s success lies in its patented technology. With ... of 15,000 pulses per minute, the device applies foundation ...
(Date:9/2/2014)... 2014 Innovations Television, produced by ... content for upcoming episodes of Innovations, focusing on ... 2015. , Innovations, hosted by Ed Begley, Jr., ... breakthroughs and advancements taking place in all areas ... advancements in biosciences. Biosciences are at the core ...
Breaking Medicine News(10 mins):Health News:High Quality 1997-2006 JEEP Wrangler TJ Leather Seat Covers From Popular Supplier Lseat.com 2Health News:When a Mood Swing Signals Trouble, From the September 2014 Harvard Health Letter 2Health News:New Report Illustrates That Even Brief Asbestos Exposure Can Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3Health News:Exciting New Episodes of Innovations with Ed Begley Jr to Air via Discovery Channel 2
... Ill., May 13 Z Trim Holdings, Inc.,(Amex: ... statements,for the fiscal year ended December 31, 2007 contained ... accounting,firm, Blackman Kallick LLP. This announcement is being made ... which requires separate disclosure,of receipt of an audit opinion ...
... today signed three bills into law:, Senate Bill ... pharmacies, under the supervision of the State Board of,Pharmacy, ... Under the program, drugs may be returned to an ... their original packaging and the,drug expires no sooner than ...
... Company Management to discuss the benefits of Hemodiafiltration therapy and ... of Life for End-Stage Renal Disease Patients, NEW YORK, ... device company developing and marketing products designed to,improve the quality ... the critical financial and clinical needs of the care,provider, today ...
... May 13 eDiets.com,Inc. (Nasdaq: DIET ), leveraging ... healthy lifestyle solutions to everyone, today announced,results for the ... first quarter of 2008 were $8.8 million, compared to,$8.4 ... for the quarter,was $(5.1) million, or $(0.20) per diluted ...
... heres another reason to encourage your daughters to be physically ... ages of 12 and 35 have a substantially lower risk ... less active, new research shows. , In the largest ... exercise on premenopausal breast cancer, the study of nearly 65,000 ...
... underwent circulatory procedure , , TUESDAY, May 13 (HealthDay ... that the clot-preventing drug Plavix could help in the ... suitable for dialysis for kidney patients. , Giving Plavix ... would block the vessel created by combining a vein ...
Cached Medicine News:Health News:Z Trim Holdings, Inc. Audit Report Contains 'Going Concern' Qualification 2Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 2Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 3Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 4Health News:eDiets.com(R) Announces Q1 2008 Results 2Health News:eDiets.com(R) Announces Q1 2008 Results 3Health News:eDiets.com(R) Announces Q1 2008 Results 4Health News:eDiets.com(R) Announces Q1 2008 Results 5Health News:eDiets.com(R) Announces Q1 2008 Results 6Health News:Girls, young women can cut risk of early breast cancer through regular exercise 2Health News:Blood-Thinner No Help for Dialysis Treatment 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: